Jinfo BlogNews in the Pharma Landscape

Tuesday, 23rd December 2014 Sign in to MyJinfo or create an account be able to star items Click for printable version Subscribe via RSS to get updates as soon as Blog items are added Tweet about this item on Twitter Share on Facebook Share on LinkedIn

By Ashish Shukla

« Blog


Ashish Shukla outlines the four major categories of information needs in the pharmaceutical industry and debates the value of general news sources vs specialist.


FreePint Topic Series: News, and BeyondThe pharmaceutical sector is a knowledge-driven industry and every company operating in this sector invests a substantial amount in keeping its executives well informed. However, owing to the varied stakeholders it represents, the information needs of the pharmaceutical sector are diverse.

There are four major information categories in the pharmaceutical sector. 

Below is the tabular listing of each category and the potential consumers:

Click to view


General News Sources are of Limited Use

Every reputable newspaper has a dedicated science/business/health column where they cover news related to the pharmaceutical sector. They are good for general reading but not for learning in-depth about key events.

Also, most of the time, the focus of the news is the commercial implications (like company financial reports, mergers and acquisitions, regulatory approval). This means that consumers who are mainly interested in scientific and early clinical events will not find these sources useful.


Are There Dedicated News Sources That Are Reliable and Up To Date?

I've aimed to answer the question "Which news sources could pharma executives reliably use?" in my article "Specialist News Offerings - Pharma Sector". 

In this article have zeroed in on three news sources that not only provide information but also analyse events from multiple angles and present "insights": FirstWord Pharma, Oncology Business Review (OBR) and Pharma & MedTech Business Intelligence. 

This Blog Item is part of the FreePint Topic Series: News, and Beyond.

« Blog

Benefit from our research

Content and Community

Claire Laybats, Head of Commercial DevelopmentConnect your team with the practical tools, original research and expertise to build and support information strategy in your organisation.

A Jinfo Subscription gives access to all Content (articles, reports, webinars) and Community.

Subscription benefits


Robin Neidorf, Head of ConsultingOur proven processes, resources and guidance will help your team make the shift from transaction centre to strategic asset.

Read case studies, and start the conversation.

Consulting benefits